Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Bourbulas who wrote (2495)	10/3/1999 11:00:00 PM
From: Walter Morton	Read Replies (1) of 2742

It seems that they are making some tough decisions to make the company profitable. But lets consider that CIST is going to sell the company in parts. What value would you apply to: The $31 million deal with PMC? The new ICE product? The IL-1X patents? PAI-2 patent that is in Phase II clinical trials ("The current estimate is that the results of the trials will come about July, 2000.")? "Cistron granted a sublicense to the PAI-2 DNA Patents to Biotech to make, use and sell PAI-2 protein for therapeutic products in the U.S. Cistron has been advised by Biotech that it opened an Australian manufacturing facility in October 1994, concluded a preliminary safety study using PAI-2 to treat leg ulcers, initiated a 20 patient clinical trial on patients with leg ulcers, which was co-funded by the Australian government, and is currently in a 130-140 patient Phase II trial." Remember this email from Biotech Australia: Message 11204892 I would not be surprised if R&D Systems of Techne (TECH) merged with CIST. Also, don't forget that Biotech Australia is looking for a partner.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next